HIMS - Leadership updates

If elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, tech, and consumer expertise Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company's 2026 annual shareholder meeting in June. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428343333/en/If elected, the marketing leader from transformative companies like DoorDash and Meta will join a diverse board with medical, tech, and consumer expertise. Amoo-Gottfried is a seasoned marketing l

The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company's first Chief Policy Officer. In this new role, Autor will collaborate with other stakeholders, including consumers, telehealth platforms, providers, advocacy groups, medical associations, pharmaceutical companies, medtech innovators, policymakers, and regulators, with the goal of paving the way to the healthcare of the future - where the power of technology will be combined with the best of personalized care. She will lead the company's global public policy, regulatory, and government affairs functions. A former senior leader at the FDA, prosecutor f

Mo Elshenawy joins as the company doubles down on the role AI will play in the next generation of healthcare. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company's new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers accelerates its vision to build the next-generation healthcare platform, powered by AI and designed to deliver deeply personalized, accessible care at scale. This press release features multimedia. View the full release here: https://www.businesswire

Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A seasoned executive known for scaling trusted consumer and healthcare logistics businesses, Kabbani will oversee operations as the company expands access to personalized care for millions more individuals. This press release features multimedia. View the full release here: https://www.businesswire.com/ne

The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company's high standard of quality and safety Hims & Hers Health, Inc. ("Hims & Hers") (NYSE:HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality,

The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation SAN FRANCISCO, Oct. 22, 2024 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Bruce Broussard, former CEO and president of Humana (NYSE:HUM), has joined the firm as venture partner. Bruce will play a pivotal role at Define, leveraging his invaluable experience scaling companies and fostering innovation within private startups, mid-size companies, and the Fortune 50. He will partner closely with Define founders to scale their businesses and become category-defining companie

NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Kåre Schultz to the company's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240722754740/en/Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions. (Pho

Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company's Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official. This press release features multimedia. View the full release here: https://www.businesswire.com

Payne joins Hims & Hers board of directors to help the company further build on its leadership position within the personalized health and wellness space Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Christopher Payne to the company's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240403772620/en/Payne joins Hims & Hers board of directors to help the company further build on its leadership position within the personalized health and wellness space. (Photo: Business Wire) "Christopher brings extensive experience working dir

Dr. Daniel Lieberman was previously a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company's Senior Vice President of Mental Health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230314005429/en/(Photo: Business Wire) In this role, Dr. Lieberman will oversee the psychiatry and

Dr. Scott Knoer was previously Chief Pharmacy Officer at Cleveland Clinic & CEO of the American Pharmacists Association Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today made a key leadership appointment, naming pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company's first-ever Chief Pharmacy & Innovation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221205005225/en/Dr. Scott Knoer, Chief Pharmacy & Innovation Officer at Hims & Hers (Photo: Business Wire) In this

New executives bring experience from Google, Skype, Walmart & Amazon Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, has added two high-profile executives to its leadership ranks as the company continues to deliver improving financial performance, including rapid topline growth and increasing scale. Silicon Valley communications veteran Brian O'Shaughnessy has been appointed the company's first Chief Communications Officer. Josh Krueger has been named VP of Fulfillment Operations, bringing over a decade of experience in fulfillment leadership roles at Walmart an

Parekh brings experience scaling high-growth companies & adds to recent leadership appointments as Hims & Hers continues to post strong growth Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has appointed Uber veteran Amee Parekh as the company's Senior Vice President of Human Resources. Parekh brings a background helping high-growth companies scale and is the latest leadership appointment as Hims & Hers continues to post rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220301005100/en

Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a number of leadership appointments that firmly position the company for success in pursuit of its mission to transform the legacy healthcare and wellness industry. The company has named Yemi Okupe – a PayPal, eBay, Google, Braintree, and Uber veteran with a decade of experience scaling high-growth, industry-disrupting companies – as Chief Financial Officer. Additionally, Hims & Hers Chief Medical Officer Dr. Patrick Carroll is being elevated to the company's Board of Directors. This press releas

Jay Spitzer Joins the Company After Over a Decade at Walgreens Boots Alliance Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has appointed Jay Spitzer, CFA as Senior Vice President of Investor Relations. Spitzer joins Hims & Hers from Walgreens Boots Alliance, Inc. where he spent over a decade in investor relations and financial leadership positions. Most recently, Spitzer served as the Vice President of Investor Relations for WBA. This year, the WBA investor relations team was named one of America's best IR teams by Institutional Investor. Spitzer was als

Smooth six month transition plan in place; The search for Company's next CFO has begun; Company reaffirms Q3 and FY 2021 guidance Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to consumers, today announced that Spencer Lee plans to step down from his role as the company's Chief Financial Officer. Lee, who joined the company in March 2019, will lead a six month transition plan and continue to support the company until a new CFO is appointed to ensure a smooth transition. The search for a new Chief Financial Officer has begun and is being led by Co-Founder and CEO Andrew Dudum

Responsible for driving continued growth across an expanding number of telehealth specialties, Mike Chi brings vast experience to help expand fast-growing expansion categories On the heels of strong Q2 earnings, Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS) has appointed Mike Chi as the company's first-ever Chief Growth Officer. Chi brings a wealth of experience in the women's market and will be responsible in this new role for driving continued growth across Hims & Hers' multi-specialty telehealth platform. "Mike has a proven record of delivering strong results, specifically when it comes to driving growth in traditionally women's focused markets," said Andrew Dudum, CEO of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced the appointment of Andrea Perez and Ambar Bhattacharyya to the company’s Board of Directors. Following the company’s recent entry onto the NYSE, Perez and Bhattacharyya join Hims & Hers at a pivotal moment not only for the brand, but at an inflection point in the healthcare industry as the COVID-19 pandemic has accelerated the need for equitable access to healthcare and highlighted the value of telemedicine. “As we continue our work of reimagining the modern healthcare experience,